期刊文献+

儿科重症监护病房先天性心脏病术后肺炎克雷伯杆菌感染临床特点及药敏分析 被引量:5

Clinical characteristics and drug sensitivity analysis of Klebsiella pneumoniae infection in children after surgery of congenital heart disease in the pediatric intensive care unit
下载PDF
导出
摘要 目的探讨儿科重症监护病房先天性心脏病术后肺炎克雷伯杆菌(Klebsiella pneumoniae,KP)-呼吸机相关性肺炎(ventilator-associated pneumonia,VAP)的临床特点及细菌耐药性分析。方法总结广东省人民医院儿科重症监护病房2014年1月至2015年12月先天性心脏病术后确诊KP-VAP患儿31例的临床资料及药物敏感试验结果。结果 2014年1月至2015年12月医院获得性肺炎患儿432例,先天性心脏病术后KP-VAP患儿31例(7.1%)。敏感抗生素分别为亚胺培南(泰能)(100.0%),头孢替坦(100.0%),厄它培南(100.0%),阿米卡星(100.0%),哌拉西林/他唑巴坦(87.2%),左氧氟沙星(87.2%),环丙沙星(87.2%);前5位耐药抗生素分别为氨苄西林(100.0%),氨苄西林/舒巴坦(84.0%),头孢曲松(80.7%),头孢唑啉(70.9%),呋喃妥因(58.1%),复方新诺明(51.6%)。结论先天性心脏病术后KP-VAP感染,在4个月龄以下婴儿感染率相对较高;经验性治疗可选用亚胺培南、厄它培南、哌拉西林/他唑巴坦、阿米卡星。 Objectives To investigate the clinical characteristics and drug sensitivity of Klebsiella pneumoniae(KP)infection in children with ventilator-associated pneumonia(VAP)after surgery of congenital heart disease in the pediat?ric intensive care unit(PICU).Methods A total of31patients with VAP caused by KP in PICU of Guangdong Gener?al Hospital from Janurary2014to December2015were investigated retrospectively.The drug resistance profile of KP was analyzed.Results There were432critically ill children received hospital acquired pneumonia in PICU from Janurary2014to December2015.Of these patients,there were31children received surgery of congenital heart disease infected with KP-VAP,the incidence rate was7.1%(31/432).Antibiotic susceptibility test showed that imipenem was the most susceptible antibiotic(100%),followed by cefotetan(100.0%),ertapenem(100.0%),amikacin(100.0%),piperacillin/tazobactam(87.2%),levofloxacin(87.2%),ciprofloxacin(87.2%).Drug resistance rate ofKP was ampicillin(100.0%),ampicillin/sulbactam(84.0%),ceftriaxone(80.7%),cefazolin(70.9%),nitrofuranto?in(58.1%)and cotrimoxazole(51.6%).Conclusions Patients less than4months old suffering from surgery of con?genital heart disease are prone to KP infection.Imipenem,ertapenem and piperacillin/tazobactam,amikacin are the best options for KP-VAP treatment.
作者 阳爱梅 郭予雄 侯铁英 胡燕 孙跃玉 昌艳军 林晓源 何少茹 YANG Ai-mei;GUO Yu-xiong;HOU Tie-ying;HU Yan;SUN Yue-yu;CHANG Yan-jun;LIN Xiao-yuan;HE Shao-ru(Department of Pediatric Intensive Care Unit,Guangdong General Hospital,Guangdong Academic of Medical Sciences,Guangzhou 510080,China;Department of Hospital Infection-Control Department,Guangdong General Hospital,Guangdong Academic of Medical Sciences,Guangzhou 510080,China)
出处 《岭南心血管病杂志》 2017年第6期718-721,共4页 South China Journal of Cardiovascular Diseases
基金 广东省协同创新与平台环境建设专项基金(项目编号:2015A050502033)
关键词 先天性心脏病 肺炎克雷伯杆菌 药敏分析 呼吸机相关性肺炎 儿童 congenital heart disease Klebsiella pneumoniae drug sensitivity analysis ventilator-associated pneumonia children
  • 相关文献

参考文献10

二级参考文献74

  • 1闫记,王慧珠,郑喜邦,成军.产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯杆菌耐药性分析及CTX-M酶的检测[J].中华实验和临床感染病杂志(电子版),2008,2(4):286-293. 被引量:6
  • 2谈林华,朱雄凯,俞建根,舒强,张泽伟,李建华,何小军.婴儿先天性心脏病术后呼吸机相关性肺炎致病菌及耐药性分析[J].中华急诊医学杂志,2005,14(3):225-228. 被引量:5
  • 3王贺,徐英春,陈民钧.细菌质粒介导的喹诺酮类抗菌药物耐药机制研究进展[J].中华医院感染学杂志,2007,17(5):618-620. 被引量:151
  • 4张群,席淑华,谢少飞,薛静洁,彭洁洁.普通外科围手术期抗菌药物合理使用的干预对照研究[J].中国感染控制杂志,2007,6(4):247-249. 被引量:33
  • 5Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosoeomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study[J].Clin Infect Dis,2004,39(3):309- 317.
  • 6Bouza E, San Juan R, Munoz P,etal. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection[J]. Clin Microbio Infect, 2001,7(10) : 532-542.
  • 7HidronAI, Edwards JR, Patel J,et al.Antimicrobial resistant pathogens associated healthcare-associated infections: annual summary of date reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007[J].Infect Control Hosp Epidemiol, 2008, 29 (11) :996-1011.
  • 8Rahal J J,Urban C,Segal-Manrer S.Nosocomial antibiotic resistance in multiple Gram-negative species:experience at one hospital with squeezing the resistance balloon at multiple sites[J].CID,2002,34:499-503.
  • 9Bradford P A.Extended-spectrum β-lactamases in 21st century characterization epidemiology and detection of this important resistance threat[J].Clin Microbiol Rev,2001,14:933-951.
  • 10Livemore D M.β-lactamases in labo-ratory and clinical resistance[J].Clin Microbiol Rew,1995,8:557.

共引文献550

同被引文献52

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部